OpGen (NASDAQ:OPGN) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note published on Wednesday morning. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Up 3.0 % NASDAQ OPGN opened at $0.52 on Wednesday. OpGen has a 12 month low of $0.17 and a 12 month […]

Leave a Reply

Your email address will not be published.

Previous post Sibanye Stillwater (NYSE:SBSW) Lowered to Sell at Jefferies Financial Group
Next post Evolve Transition Infrastructure (NYSE:SNMP) Receives New Coverage from Analysts at StockNews.com